Por: MarketWatch Business October 19, 2022
Since the S&P 500 peaked on Jan. 3, the broader index is down 22%, while the healthcare index is down 10%. That is nowhere close to the index, which is up 47.4%, but it’s a lot better than the , down 37.2%. Investors have fled to certain healthcare subsectors as defensive plays to shield their assets from the shambles of the broader market. That dynamic helped healthcare through the early parts of the year, cushioning the blows that fell... + full article
Forbes USA Business October 15, 2022
Getty Images Key Takeaways You may have heard the overwhelmingly positive news for Biogen lately—this stock has been a rare winner during a time of extreme volatility in the stock market due to consistent rate hikes. Biogen Inc. (BIBB) is one of the older global biotech... + más
Biogen to pay $900M to settle allegations of improper physician kickbacks | Fox Business
Biogen to pay $900 million to settle allegations it paid doctors kickbacks to prescribe multiple sclerosis drugs | CNBC
Newsweek USA Life October 04, 2022
The intense moment a bear caught a man and his partner by surprise while walking their dogs was caught on camera and has since gone viral.After being alerted by his dogs to the bear's presence, the footage showed the man springing into action as he is seen growling and... + más
Hunters discuss killing Michigan's one-in-a-million 'spirit bear' | Newsweek
Bile bear found rocking back and forth rescued after 17 years of abuse | Newsweek
Fox Business USA Business September 28, 2022
Dr. Stephen O'Brien, chief medical officer of Mediflix, shares how his streaming platform is trailblazing access to medical information for everyone. Shares of Biogen surged Wednesday's following news that its drug lecanemab showed promising signs of potentially... + más
Biogen shares rally as Alzheimer's drug results show promise | CBS News
Alzheimer's drug shows promise in early results of study | WPLG Local 10
The Boston Globe USA Business September 27, 2022
LIFE SCIENCESBiogen to pay $900m to settle whistle-blower suit over kickbacksAfter a decade of litigation, Biogen has agreed to pay $900 million to settle a federal whistle-blower lawsuit by a former employee who accused the Cambridge-based drug firm of paying kickbacks to... + más
Biogen pays $900m to settle whistle-blower suit over kickbacks | The Boston Globe
Orlando Sentinel USA Business September 27, 2022
BOSTON — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said. The agreement announced Monday settles a whistleblower... + más
Biogen pays $900M to settle doctor kickback allegations | ABC News
Fox Business USA Business September 27, 2022
Aflac Chairman and CEO Dan Amos says record-high inflation poses a ‘challenging environment’ for consumers. Biogen has to settle allegations that it paid kickbacks to persuade doctors to prescribe its multiple sclerosis drugs. The settlement comes after former Biogen... + más
Biogen to pay $900m to settle whistle-blower suit over kickbacks | The Boston Globe
CNBC USA Health September 27, 2022
In this articleA Biogen facility in Cambridge, Massachusetts.Brian Snyder Reuters will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its drugs, the Justice Department announced on Monday.A former Biogen employee... + más
About iurex | Privacy Policy | Disclaimer |